RMD (ResMed Corp) EV/EBITDA Multiple
ResMed Inc. (RMD) leads in apnea therapy, leveraging a digital ecosystem to ensure customer retention and stable earnings. A protected non-cyclical business profile provides sales resilience regardless of economic conditions. The AirView cloud service strengthens market positioning by creating barriers that prevent physicians from switching to competing solutions. The company's EV/EBITDA ratio, accounting for debt load, clearly demonstrates valuation dynamics on this chart, while 14.91 determines the latest valuation metric.
Summary analytical data breakdowns for resmed.com (RMD)
- stock price and consensus target price:
- business market valuation indicators:
- issuer book value statistics:
- debt and liquidity data:
- financial results and valuation multiples details:
RMD - Net Income|Projected Future Earnings ResMed Inc.|RMD - P/E Multiple|Future Price to Earnings ResMed Inc.|RMD - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio ResMed Corporation|RMD - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) ResMed|RMD - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months resmed.com|RMD - Net earnings per share change in current year|Expected earnings per share growth for next year ResMed Inc.
Initial company analysis:ResMed Corp RMD
ResMed Inc. maintains strong pricing power in the CPAP therapy segment, ensuring a steady cash flow. This business valuation level via EV/EBITDA compares the total enterprise value, including net debt, against operating profit. This chart reflects the current market consensus regarding asset efficiency. Analyzing this metric determines whether the current valuation is fair or if the market is pricing in stagnation risks.
Competitor analysis for ResMed Inc.
Boston Scientific Inc - Enterprise Value to EBITDA Ratio|EW (Edwards Lifesciences Inc.) - Company Value to Operating Income Before Depreciation Ratio|Insulet Corporation - EV/EBITDA Multiple|Company Value to EBITDA Zimmer Biomet Holdings Inc|COO: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ALGN|Enterprise Value to EBITDA Ratio GMED|TMDX: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alphatec Holdings, Inc. (ATEC)|Enterprise Value to EBITDA Ratio artivion.com AORT|EV/EBITDA Multiple ENOV (Enovis)|Integra LifeSciences Corp (IART) - Company Value to EBITDA|Motiva - EV/EBITDA Multiple|BBNX (iLet Bionic Pancreas) - Enterprise Value to Operating Income Before Depreciation|IRMD: EV/EBITDA Multiple|EMBC - Total Company Value to Operating Income Before Depreciation Ratio|TNDM (Tandem Diabetes Care, Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio AxoGen Inc (AXGN)|EV/EBITDA Multiple SIBN|EV/EBITDA Multiple Orthofix Corp (OFIX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bioventus Inc. BVS|OrthoPediatrics Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation SRTA (Blade Air Mobility)|CARL: EV/EBITDA Multiple|Company Value to EBITDA RxSight Ophthalmic (RXST)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ClearPoint Neuro Inc.|STXS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio STIM (Neuronetics)|EV/EBITDA Multiple Sight Sciences Inc. (SGHT)|EV/EBITDA Multiple OBIO (Orchestra BioMed)|Total Company Value to Operating Income Before Depreciation Ratio Anika Therapeutics Inc. (ANIK)|NSPR - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Xtant Medical|NMTC (NeuroOne Corp) - EV/EBITDA Multiple|Company Value to EBITDA Modular Med MODD|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Myomo, Inc. (MYO)|envoymedical.com - Enterprise Value to Operating Income Before Depreciation|Vivos Therapeutics, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio NVNO (enVVeno Medical Corporation)|SINT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation TNON (Tenon Medical Inc)|LFWD: EV/EBITDA Multiple|Company Value to EBITDA Autonomix Medical (AMIX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Fertility|Bone Biologics Corp. (BBLG) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Axonics Modulation Technologies (AXNX)|Enterprise Value to EBITDA Ratio Biolase Inc. BIOL|EV/EBITDA Multiple DYNT (Dynatronics)|Paragon 28 Inc. (FNA) - Company Value to EBITDA|INVO Bio - EV/EBITDA Multiple
